SCHEDULE 13G

Statement of Beneficial Ownership

MoonLake Immunotherapeutics Filed 2025-08-14 Acc 0000902664-25-003575

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-14 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)